Pamidronate therapy for hypercalcemia and congenital mesoblastic nephroma: A case report

8Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hypercalcemia can causes life threatening complications. We report an infant with severe hypercalcemia due to congenital mesoblastic nephroma. Hypercalcemia was corrected before nephrectomy by pamidronate. According to our knowledge this is a rare case with severe neoplasm induced hypercalcemia among neonates who treated by bisphosphonates. The aim of this report is to define new approach to neoplasm induced neonatal hypercalcemia. © 2009 Soheilipour et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Soheilipour, F., Amineh, M. A., Hashemipour, M., Kojoor, A. A. S., & Jazi, A. H. D. (2009). Pamidronate therapy for hypercalcemia and congenital mesoblastic nephroma: A case report. Cases Journal, 2(12). https://doi.org/10.1186/1757-1626-2-9315

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free